China Mobile Limited (BKK:CHMOBILE19)

Aerovate Therapeutics Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,810,771	7,479,214	6,278,152	5,000,367	4,080,395	3,504,007
Market Cap Growth	17.18%	19.13%	25.55%	22.55%	16.45%	-31.62%
Enterprise Value	6,671,886	6,324,846	5,109,112	3,324,898	1,689,405	1,729,745
PE Ratio	11.97	11.49	9.83	7.95	6.73	7.07
PS Ratio	1.60	1.53	1.28	1.06	0.92	0.99
PB Ratio	1.20	1.17	0.99	0.79	0.66	0.66
P/TBV Ratio	1.24	1.22	1.03	0.82	0.69	0.70
P/FCF Ratio	12.62	9.96	10.57	10.94	7.27	6.45
P/OCF Ratio	5.75	5.04	4.26	3.55	2.48	2.48
EV/Sales Ratio	1.44	1.29	1.04	0.71	0.38	0.49
EV/EBITDA Ratio	4.80	4.58	3.04	1.97	1.03	1.44
EV/EBIT Ratio	10.24	9.33	7.56	4.85	2.69	3.29
EV/FCF Ratio	10.78	8.42	8.60	7.28	3.01	3.18
Debt / Equity Ratio	0.07	0.07	0.08	0.09	0.05	0.06
Debt / EBITDA Ratio	0.30	0.27	0.30	0.33	0.18	0.23
Debt / FCF Ratio	0.72	0.55	0.84	1.24	0.53	0.56
Asset Turnover	0.51	0.52	0.52	0.51	0.48	0.46
Inventory Turnover	59.39	63.56	61.09	61.84	66.22	48.62
Quick Ratio	0.85	0.79	0.74	0.73	0.88	1.05
Current Ratio	0.93	0.90	0.89	0.86	1.02	1.12
Return on Equity (ROE)	10.20%	10.37%	10.24%	10.29%	9.98%	9.57%
Return on Assets (ROA)	4.49%	4.47%	4.52%	4.61%	4.25%	4.25%
Return on Capital (ROIC)	6.26%	6.29%	6.24%	6.55%	6.13%	5.95%
Return on Capital Employed (ROCE)	9.90%	10.00%	10.00%	10.00%	9.80%	9.40%
Earnings Yield	8.35%	8.70%	10.18%	12.57%	14.85%	14.15%
FCF Yield	7.92%	10.04%	9.46%	9.14%	13.76%	15.51%
Payout Ratio	70.00%	70.51%	69.18%	69.29%	49.84%	55.38%
Buyback Yield / Dilution	-0.72%	-0.63%	-0.29%	-4.26%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.